Gus Alva
Impact in
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Neurology top 10%
- Transcranial Magnetic Stimulation Studies
Papers in
-
- Schizophrenia research and treatment 4
- Dementia and Cognitive Impairment Research 1
-
- Tryptophan and brain disorders 2
- Co-authors
- Steven G. Potkin (6 shared papers)D. Carreon (3 shared papers)Vincenzo S. Basile (2 shared papers)Mario Masellis (2 shared papers)James L. Kennedy (2 shared papers)Yi Jin (2 shared papers)Xiangyi Meng (3 shared papers)W.E. Bunney (2 shared papers)
- Journals
- Molecular Psychiatry (2 papers)Schizophrenia Research (2 papers)Journal of Alzheimer s Disease (1 paper)Alzheimer s & Dementia (1 paper)Schizophrenia Bulletin (1 paper)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Gus Alva
12 papers receiving 421 citations
Peers
Comparison fields: 5 of 58
- Psychiatry and Mental health 191
- Neurology 85
- Biological Psychiatry 20
- Pharmacology 68
- Cognitive Neuroscience 62
Countries citing papers authored by Gus Alva
This map shows the geographic impact of Gus Alva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gus Alva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gus Alva more than expected).
Fields of papers citing papers by Gus Alva
This network shows the impact of papers produced by Gus Alva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gus Alva. The network helps show where Gus Alva may publish in the future.
Co-authors
The 25 scholars most cited alongside Gus Alva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 132 | |
| 2 | 2005 | 99 | |
| 3 | 2003 | 84 | |
| 4 | 2009 | 46 | |
| 5 | 2014 | 17 | |
| 6 | 2015 | 16 | |
| 7 | 2006 | 14 | |
| 8 | 2024 | 8 | |
| 9 | 2014 | 7 | |
| 10 | 2012 | 5 | |
| 11 | 2003 | 2 | |
| 12 | Predicting Clinical Antipsychotic Doses from Preclinical and PET studies: A Case Study with Asenapine | 2003 | 1 |
About Gus Alva
Gus Alva is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Cognitive Neuroscience, Genetics and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 431 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (4 papers), Tryptophan and brain disorders (2 papers), Functional Brain Connectivity Studies (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Cerebrospinal fluid and hydrocephalus (1 paper), Transcranial Magnetic Stimulation Studies (1 paper), Bayesian Modeling and Causal Inference (1 paper) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Psychiatry and Mental health (191 citations), Neurology (85 citations), Biological Psychiatry (20 citations), Pharmacology (68 citations) and Cognitive Neuroscience (62 citations). Gus Alva has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Steven G. Potkin, D. Carreon, Vincenzo S. Basile, Mario Masellis, James L. Kennedy, Yi Jin, Xiangyi Meng, W.E. Bunney, Jason T. Olin and Herbert Y. Meltzer. Their work appears in journals such as Molecular Psychiatry, Schizophrenia Research, Journal of Alzheimer s Disease, Alzheimer s & Dementia and Schizophrenia Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.